GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » McMillan Shakespeare Ltd (ASX:MMS) » Definitions » Research & Development

McMillan Shakespeare (ASX:MMS) Research & Development : A$0.0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2004. Start your Free Trial

What is McMillan Shakespeare Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. McMillan Shakespeare's Research & Development for the six months ended in Dec. 2024 was A$0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was A$0.0 Mil.


McMillan Shakespeare Research & Development Historical Data

The historical data trend for McMillan Shakespeare's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

McMillan Shakespeare Research & Development Chart

McMillan Shakespeare Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

McMillan Shakespeare Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

McMillan Shakespeare Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


McMillan Shakespeare  (ASX:MMS) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


McMillan Shakespeare Research & Development Related Terms

Thank you for viewing the detailed overview of McMillan Shakespeare's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


McMillan Shakespeare Business Description

Traded in Other Exchanges
Address
360 Elizabeth Street, Level 21, The Tower, Melbourne Central, Melbourne, VIC, AUS, 3000
McMillan Shakespeare is a provider of salary packaging, novated leasing, disability plan management and support co-ordination, and fleet management services. It actively works to cross-sell its products to clients, for example, selling its salary packaging services to its fleet management customers in Australia and New Zealand. McMillan dominates Australia's salary packaging market together with Smartgroup (also covered by Morningstar), and is also Australia's largest provider of novated leasing services by volumes—marginally ahead of Smartgroup and SG Fleet. The group has three operating segments: group remuneration services, asset management services, and plan and support services. Most of the group's revenue is generated from the group remuneration services segment.